Ep. 8 ”Finding Home: Migrants and Displaced People”

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/51/9e/2e/519e2efd-00d4-2f8c-7af7-a14d36ac73ca/mza_4524727561548769437.png/600x600bb.jpg

Zero Hour

Gilead Sciences

12 episodes

6 months ago

No more silence. No more ambiguity. These conversations with global health experts, activists, and change makers bring you the candid truth about HIV—from the harrowing to the hopeful. Zero Hour™ is a global podcast brought to you by Gilead Sciences, hosted by Drs. C. Chauncey Watson and David Malebranche, and made for anyone providing HIV care, living with HIV, or just wanting to learn more.

All content for Zero Hour is the property of Gilead Sciences and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Sexuality

Health & Fitness,

Medicine

Ep. 8 ”Finding Home: Migrants and Displaced People”

Zero Hour

33 minutes 25 seconds

2 years ago

Ep. 8 ”Finding Home: Migrants and Displaced People”

Leaving home is never easy—especially when discrimination, xenophobia, and cultural barriers await you in your new destination. In this episode, Zero Hour™ speaks with two leaders who are working to not only ease the transition for migrants and displaced people, but to also connect them with vital HIV services and resources. Our guests are: Denis Onyango, a grassroots activist who organizes HIV testing, prevention, and peer support services through his role as Programs Director for the Africa Advocacy Foundation. He reflects on how losing his brother and three sisters to AIDS spurred his focus on HIV activism, as well as the harsh realization that the care they went without was widely available in other parts of the world. Isjed Hussain, founder of the Prisma Group Foundation, which supports bicultural and Muslim LGBTQ people in the Netherlands. They explain how Prisma helps refugees to navigate the asylum process and how they assist refugees living with HIV. This podcast was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved. US-UNBC-1760 Date of Preparation August 2023. Correction: Guest states that a study took place with 3000 participants in 10 countries. In actuality, the study took place in 9 countries with 2009 participants. References: Alvarez-Del Arco D. et al, AIDS, 2017; 31(14):1979-1988. Accessed August 23, 2023 European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2021 – 2020 data. Stockholm: ECDC; 2021. Accessed July 15, 2023. Available at: https://www.ecdc.europa.eu/en/publications-data/hiv-aids-surveillance-europe-2021-2020-data European Centre for Disease Prevention and Control. HIV and migrants. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report. Stockholm: ECDC; 2019. Accessed July 15, 2023. Available at: https://www.ecdc.europa.eu/en/publications/hiv-migrants-monitoring-implementation-dublin-declaration-2018-progress-report Frescura L, Godfrey-Faussett P, Feizzadeh A A, El-Sadr W, Syarif O, Ghys PD; on behalf of the 2025 testing treatment target Working Group. Achieving the 95 95 95 targets for all: A pathway to ending AIDS. PLoS One. 2022 Aug 4;17(8):e0272405. doi:10.1371/journal.pone.0272405. Gbadamosi SO, Trepka MJ, Dawit R, Jebai R, Sheehan DM. A Systematic Review and Meta-analysis to Estimate the Time from HIV Infection to Diagnosis for People with HIV. AIDS Rev. 2022 Mar 1;24(1):32-40. doi: 10.24875/AIDSRev.21000007. PMID: 34077404; PMCID: PMC8636511. Accessed August, 23 2023 US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. March 2023. Accessed July 15, 2023. Available at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf